Jane Street’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$62K Buy
15,700
+200
+1% +$1.01K ﹤0.01% 10886
2025
Q4
$105K Sell
15,500
-14,400
-48% -$101K ﹤0.01% 10164
2025
Q3
$209K Buy
29,900
+6,000
+25% +$41.7K ﹤0.01% 9594
2025
Q2
$146K Buy
+23,900
New +$159K ﹤0.01% 8768
2022
Q2
Sell
-26,000
Closed -$122K 10403
2022
Q1
$122K Sell
26,000
-86,900
-77% -$425K ﹤0.01% 9358
2021
Q4
$682K Buy
112,900
+3,700
+3% +$25.7K ﹤0.01% 6684
2021
Q3
$662K Buy
109,200
+96,700
+774% +$1.09M ﹤0.01% 6749
2021
Q2
$156K Buy
+12,500
New +$135K ﹤0.01% 9021

Other funds holding MDXG

Jane Street's MDXG Position: Q1 2026 in Review

Jane Street increased its MiMedx Group (MDXG) stake by 103% in Q1 2026, buying an estimated $1.34M and bringing the position to 525,472 shares worth $2.08M. The position accounts for ﹤0.01% of the portfolio, ranked #5018.

Jane Street first reported a position in MDXG in Q3 2013 and has held it in 24 quarters since. The position peaked at $3.71M in Q4 2024. 237 funds tracked by Wall St. Rank hold MDXG as of Q1 2026.

  • Jane Street held 525,472 shares of MiMedx Group worth $2.08M as of Q1 2026.
  • Jane Street bought 266,210 MiMedx Group shares in Q1 2026, an estimated $1.34M.
  • MiMedx Group made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #5018 holding.
  • Jane Street first reported a position in MiMedx Group in Q3 2013 and has held it in 24 quarters since.
  • Jane Street's MiMedx Group position peaked at $3.71M in Q4 2024.
  • 237 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.